Clinical Trials

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT03005743 2026-02-23

COMBAT-Cx

1,050 enrolled

Uterine Cervical Neoplasms

NCT06264167 2026-02-20

NODE

30 enrolled

Lymphatic Metastasis, Vulvar Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

20 enrolled

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT03997110 2026-02-17

RAPPAL

230 enrolled

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

140 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01279135 2026-02-06

PARCER

Phase 3 Completed

300 enrolled

Phase NA Not yet recruiting

Uterine Cervical Neoplasms

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

74 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT07050745 2026-01-12

DADA-LINK

1,980 enrolled

Uterine Cervical Neoplasms

NCT07181278 2025-12-02

OptiTri_MT

1,180 enrolled

Uterine Cervical Neoplasms

NCT06476639 2025-11-28

ANVU

640 enrolled

Phase 1/2 Not yet recruiting

Lymphatic Metastasis, Vulvar Neoplasms

NCT07245381 2025-11-24

Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

65 enrolled

Uterine Cervical Neoplasms

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

94 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT06482983 2025-11-19

The Effects of VC Versus PC Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery

120 enrolled

Anesthesia

NCT06560697 2025-10-07

SABRVICAL

84 enrolled

Uterine Cervical Neoplasms

NCT05191212 2025-09-24

Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer

80 enrolled

Phase NA Enrolling by invitation

Uterine Neoplasms, Endometrial Neoplasms

NCT06942286 2025-09-17

Primary HPV Self-Collection in Indonesia

8,000 enrolled

Phase EARLY_PHASE1 Recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07106814 2025-09-15

Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

36 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Liver Neoplasms

NCT07171528 2025-09-12

KOV-02S

80 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07113236 2025-08-21

Effectiveness of Interventions for Improving HPV Vaccination Cover

320 enrolled

Uterine Cervical Neoplasms

NCT07105553 2025-08-06

NEURO-GLOVE

76 enrolled

Ovarian Neoplasms, Peripheral Nervous System Diseases, Endometrial Neoplasms

NCT07068464 2025-07-16

ICRA

682 enrolled

Ovarian Neoplasms

NCT06839144 2025-07-11

OC-POP-PT

60 enrolled

GastrointestinalGynecologicThoracic

Neoplasms, Ovarian Neoplasms

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

20 enrolled

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Phase 1/2 Not yet recruiting

33 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01837693 2025-06-26

NTCC2

GynecologicOther neoplasm

41,127 enrolled

Uterine Cervical Neoplasms, Hypersensitivity, Neoplasms, Precancerous Conditions

NCT07025213 2025-06-17

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

80 enrolled

Endometrial Neoplasms

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

18 enrolled

Uterine Cervical Neoplasms, Renal Insufficiency

NCT06156514 2025-05-28

MICHELE

Phase 3 Recruiting

140 enrolled

Locally Advanced Cervical Cancer

NCT03994055 2025-05-25

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

136 enrolled

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Neoplasms, Radiation Injuries

NCT06080841 2025-05-25

Curcumin Supplementation in Cervical Cancer

30 enrolled

Locally Advanced Cervical Cancer

NCT06562595 2025-05-20

What is the Optimal Training Model for Cervical Awareness?

400 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06879353 2025-03-19

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

372 enrolled

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT06846424 2025-02-26

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

24 enrolled

Phase 3 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02859038 2025-02-10

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

489 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

220 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06528184 2025-02-10

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

650 enrolled

Uterine Cervical Neoplasms

NCT04846933 2025-01-16

DECIDER

200 enrolled

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

90 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT04122235 2025-01-03

LETSGO

Phase NA Active not recruiting

754 enrolled

Empowerment, Alzheimer Disease, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06278857 2024-12-03

SATELLITE

10 enrolled

Phase NA Not yet recruiting

Turcot syndrome, Endometrial Neoplasms

NCT06673511 2024-11-21

The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian Cancer

246 enrolled

Phase 2 Enrolling by invitation

Carcinoma, Ovarian Epithelial

NCT06525870 2024-11-14

Trichlosil

44 enrolled

Phase 1 Active not recruiting

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT02521844 2024-10-08

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

89 enrolled

Phase 2 Not yet recruiting

Ovarian Neoplasms, Endometrial Neoplasms

NCT06600841 2024-09-19

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

37 enrolled

Phase 2 Active not recruiting

Platinum-resistant Ovarian Cancer (PROC)

NCT01686126 2024-08-28

feMMe

165 enrolled

Endometrial Hyperplasia

NCT06542549 2024-08-07

Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer

100 enrolled

Advanced Ovarian Cancer

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

51 enrolled